Wave Life Sciences Ltd (WVE) Stock Forecast & Price Target
Wave Life Sciences Ltd · NASDAQ
$5.92+0.12 (+1.98%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering Wave Life Sciences Ltd, 13 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $13.00 to $43.00 (about 3.3x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $21.80 sits 268% above the current $5.92. The rating mix has stayed broadly stable, with Buy-side ratings easing from 14 to 13 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.31 next quarter toward $-1.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Moderate Buy
Strong Buy00%
Buy13100%
Hold00%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to Wave Life Sciences Ltd.
As of Jul, 13 of 13 firms rate WVE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
WVE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.31
Range $-0.37 – $-0.23 · 11 analysts · -4% YoY
Next period, 11 analysts expect Wave Life Sciences Ltd to earn $-0.31 a share (range $-0.37 – $-0.23), versus $-0.32 a year earlier. Full-year consensus is $-0.84, growing to $-1.08 the year after.
REVENUE · NEXT QUARTER
$7.0M
Range $0 – $20.0M · 11 analysts · -9% YoY
Revenue is expected to reach $7.0M (range $0 – $20.0M), -8.5% year-over-year. Full-year consensus is $59.1M, rising to $51.5M next year.
Top analysts covering Wave Life Sciences Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WVE.
#1
Andrew Fein
HC Wainwright & Co. · Rank #35
Buy
$13.00+119.4% to target
Overall win rate
46%
+ Follow
#2
SS
Samantha Semenkow
Citigroup
Buy
$24.00+305.1% to target
Coverage
—
+ Follow
#3
Benjamin Burnett
Wells Fargo
Buy
$14.00+136.3% to target
Coverage
—
+ Follow
#4
YZ
Yun Zhong
Wedbush
Buy
$15.00+153.2% to target
Coverage
—
+ Follow
#5
Steven Seedhouse
Cantor Fitzgerald
Buy
$13.00+119.4% to target
Coverage
—
+ Follow
WVE stock forecast FAQ
What is WVE's average 12-month price target?+
The 5 analysts with a live target average $21.80 for Wave Life Sciences Ltd over the next 12 months, ranging from a $43.00 high to a $13.00 low.
Is WVE stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 13 analyst ratings, 13 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for WVE?+
The Street-high target is $43.00 (Canaccord Genuity), and the Street-low is $13.00 (HC Wainwright & Co.). The average of all 5 active targets is $21.80.
How many Wall Street analysts cover WVE?+
13 analysts have an active rating on Wave Life Sciences Ltd, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering WVE?+
Among analysts who currently cover WVE, Andrew Fein of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #35). Their current call is Buy with a $13.00 target.
What is Wave Life Sciences Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.31 per share (range $-0.37 – $-0.23) across 11 analysts. Full-year EPS is projected at $-0.84, rising to $-1.08 the following year.
How much revenue is Wave Life Sciences Ltd expected to report next quarter?+
Consensus revenue is $7.0M (range $0 – $20.0M). Full-year revenue is projected at $59.1M, growing to $51.5M next year.
Have analysts been upgrading or downgrading WVE lately?+
As of Jul, 13 of 13 firms rate WVE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WVE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
